The effect of the level of dietary corn oil on mouse skin carcinogenesis.
To investigate the effects of two levels of dietary corn oil on tumorigenesis, semipurified diets containing 5% or 10% corn oil were fed during the promotion stage of a mouse skin carcinogenesis model. Sencar mice were initiated with 10 nmol dimethylbenz[a]anthracene (DMBA) and promoted with either 1 microgram 12-O-tetradecanoylphorbol-13-acetate (TPA) or 40 mg benzoyl peroxide twice weekly for 24 or 52 weeks, respectively. No significant differences in kilocalories of food consumed or body weights were observed between the diet groups during the study. Fatty acid profiles of the epidermal phospholipids reflected dietary fat intake. For example, high levels of linoleate and low levels of arachidonate were found in the phosphatidylcholine fraction from mice fed the 10% corn oil diet compared with 5% corn oil. When the diets were fed during TPA promotion, the papilloma incidence after 11 weeks of treatment for the 5% corn oil group was 77% and 37% for the 10% corn oil group. By 15 weeks of TPA treatment, papilloma incidence between the diet groups was similar, and later, carcinoma incidence and yield were not different between the two groups. For the animals treated with benzoyl peroxide, there was only a slight but not significant difference in papilloma and carcinoma appearance. In parallel studies, ornithine decarboxylase activity, vascular permeability, hyperplasia, and prostaglandin E2 (PGE2) levels were elevated in the epidermis after promoter treatment, but only hyperplasia and PGE2 synthesis tended to reflect the dietary effects on tumor appearance. These data suggest that the quantity of dietary corn oil at the two levels tested, 5% and 10%, altered epidermal phospholipid fatty acid composition and PGE2 levels and had modest effects on the modulation of tumorigenesis in this skin model.
Division of Nutrition, University of Texas, Austin 78712.
M
M
Locniskar
M A
MA
Belury
A G
AG
Cumberland
K E
KE
Patrick
S M
SM
Fischer
D015127:9,10-Dimethyl-1,2-benzanthracene / Q000009:adverse effects*; D000818:Animals; D001585:Benzoyl Peroxide / Q000009:adverse effects; D002199:Capillary Permeability / Q000187:drug effects; D003043:Cocarcinogenesis; D003314:Corn Oil / Q000008:administration & dosage / Q000494:pharmacology*; D004041:Dietary Fats / Q000008:administration & dosage / Q000494:pharmacology*; D015232:Dinoprostone / Q000032:analysis; D005227:Fatty Acids / Q000032:analysis; D005260:Female; D006965:Hyperplasia; D051379:Mice; D009955:Ornithine Decarboxylase / Q000032:analysis; D010743:Phospholipids / Q000032:analysis; D012867:Skin / Q000098:blood supply / Q000737:chemistry / Q000187:drug effects / Q000201:enzymology / Q000473:pathology; D012878:Skin Neoplasms / Q000098:blood supply / Q000139:chemically induced* / Q000737:chemistry / Q000201:enzymology / Q000473:pathology; D013755:Tetradecanoylphorbol Acetate / Q000009:adverse effects
D004041:Dietary Fats; D005227:Fatty Acids; D010743:Phospholipids; D015127:9,10-Dimethyl-1,2-benzanthracene; D003314:Corn Oil; D009955:Ornithine Decarboxylase; D015232:Dinoprostone; D013755:Tetradecanoylphorbol Acetate; D001585:Benzoyl Peroxide